Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Adv Drug Deliv Rev. 2017 Jun 10;113:177–200. doi: 10.1016/j.addr.2017.06.002

Figure 9.

Figure 9

Schematic illustration of the inhibition of brain tumor growth and glioma stem cells by PMLA-based nano drugs. A novel mechanism of cross-talk between protein kinase CK2, an ubiquitous serine/threonine protein kinase, and wild and mutated variant vIII (EGFR/EGFRvIII) EGFR pathways is depicted. Reproduced from [198].